For more information on how to calculate the financial value of health equity investments, please check out our Blended Value for Health Equity Course.
Conventional return on investment (ROI) analysis has always been ill-suited to define the true value of health equity and upstream efforts. In the face of federal funding cuts and economic uncertainty, join us on May 22nd to learn about a better way to calculate and communicate the value of health equity programs and social needs investments.
ROI is the traditional measure used by health systems and health plans to gauge the value of health equity interventions. Yet it’s increasingly clear that conventional ROI analysis has limitations that can obscure important health equity outcomes and undercut upstream impact. When our key metric is blind to critical benefits of health equity and social needs interventions—from health improvements and patient experience to staff retention and impacts on local economies — we risk misspending our investment dollars, missing powerful opportunities, or divesting from programs with real economic and social value. And in the end, patient health and organizational health suffer.
Health and social care leaders can more powerfully capture the full scope of their investment impact through a financial modeling method called Blended Value. This model, developed first in the field of impact investing and later adapted and tested by HealthBegins for health equity programs, combines three essential methods — return on investment (ROI), value of investment (VOI), and social return on investment (SROI) — in one quantitative approach. Together, these methods account for a broader range of benefits including financial performance, intangible economic benefits, social and community impact, reductions in inequities, and long-term health outcomes that are left out of ROI analysis alone.
In this webinar, health and economics experts will discuss key principles and core components of Blended Value. You’ll learn about real-world use cases from health and social care leaders who have applied Blended Value in their settings. And you’ll learn about opportunities to expand beyond conventional ROI analysis and calculate the Blended Value of your own health equity and social needs investments for greater impact and sustainability.
Speakers:
- Glasha Marcon, Vice President of Learning and Innovation, HealthBegins
- Rishi Manchanda, MD MPH, CEO, HealthBegins
- Len Nichols, Ph.D., Non-resident Fellow, Urban Institute, Professor Emeritus, George Mason University
- Jessica Palardy, MSW, LSW, Senior Manager, Medical Advocacy, Lutheran Settlement House
- Corey Smith, Ph.D., Director of Health Equity Evaluation, Corewell Health
Webinar Objectives:
By the end of the webinar, attendees will be able to:
- Explain the core components of a Blended Value approach and their importance, especially in times of economic uncertainty.
- Describe how Blended Value methods and financial models can enable teams to better plan, assess, and sustain their investments in population health, health equity and social needs interventions.
- Identify at least one opportunity to learn how to calculate the Blended Value of your own health equity and social needs investments for greater impact and sustainability.
Featured Content
Aligning Our Organizational Structure with Our Values
With our new B Corp Certification, HealthBegins has now joined a global network of companies that see business as a force for good and can share tools and practices to help us improve.
5 Principles and Practices to Sustain Gender-Affirming Care in Uncertain Times
With the onslaught of federal threats to transgender and nonbinary people, health care has a critical role to play to uphold standards of care, ensure access to essential services, advocate for evidence-based medicine, and protect patients and providers.
Strengthening Health Equity Investments with Human-Centered Stakeholder Engagement
Understanding and aligning with what value means to your stakeholders—especially those who make investment decisions—is crucial when making the business case for health equity investments.